Search

everythinglearnresearchcommunity

for

Search:↓

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Alpha-blockers and Finasteride effectively manage BPH symptoms long-term.

New methods for measuring dutasteride are effective and reliable.

Doxazosin may cause breast enlargement and pain in men.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Strontium ranelate is no longer available for treatment.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Medications improve quality of life for men with lower urinary tract symptoms.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

Enteric hyperoxaluria can cause severe kidney failure after bowel surgery.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

These medications for BPH have known risks and may have new side effects.